Codexis completes obligations under R&D agreement with leading biopharmaceutical company
Codexis announced completion of its obligations under a collaborative R&D agreement with a leading biopharmaceutical company. Codexis employed its CodeEvolver® protein engineering platform technology to develop a novel enzyme for use in its partner’s preclinical therapeutic development program. July 28, 2016